Form 4 for CGTX COGNITION THERAPEUTICS INC
Accepted 2023-02-07 00:00:00 ET · period of report 2023-02-03 · accession 0000899243-23-004182 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-07 | 2023-02-03 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | A - Grant | $0.00 | +214.0K | 238.5K | +873% | $0 |
| D | 2023-02-07 | 2023-02-03 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | A - Grant | $0.00 | +214.0K | 214.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-03 | A | A | 213,973 | $0.00 | 238,473 | D | — | — | (F1) Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-02-03 | A | A | 213,973 | $0.00 | 213,973 | D | $2.12 · — to 2033-02-03 | 213,973 Common Stock | (F2) The option vests 33.3% on February 3, 2024, with the remaining 66.7% vesting in 24 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates. |